NeoPharm Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast NeoPharm stock prices and determine the direction of NeoPharm LTD's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of NeoPharm's historical fundamentals, such as revenue growth or operating cash flow patterns.
NeoPharm
On December 17, 2024 NeoPharm LTD had Price Action Indicator of (40.00). Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.
On December 17 2024 NeoPharm LTD was traded for 12,000 at the closing time. The highest price during the trading period was 12,160 and the lowest recorded bid was listed for 11,910 . The volume for the day was 28.8 K. This history from December 17, 2024 did not cause price change. The trading delta at closing time to the current price is 0.08% .
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
For every potential investor in NeoPharm, whether a beginner or expert, NeoPharm's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. NeoPharm Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in NeoPharm. Basic forecasting techniques help filter out the noise by identifying NeoPharm's price trends.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NeoPharm stock to make a market-neutral strategy. Peer analysis of NeoPharm could also be used in its relative valuation, which is a method of valuing NeoPharm by comparing valuation metrics with similar companies.
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of NeoPharm's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of NeoPharm's current price.
Market strength indicators help investors to evaluate how NeoPharm stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NeoPharm shares will generate the highest return on investment. By undertsting and applying NeoPharm stock market strength indicators, traders can identify NeoPharm LTD entry and exit signals to maximize returns.
The analysis of NeoPharm's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in NeoPharm's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neopharm stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Other Information on Investing in NeoPharm Stock
NeoPharm financial ratios help investors to determine whether NeoPharm Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NeoPharm with respect to the benefits of owning NeoPharm security.